Ya-chu Tang
Miaoli, TNQ 35040, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models.
Journal: Pharmacological research
Published: June 17, 2024
How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy.
Journal: Journal of food and drug analysis
Published: February 09, 2023
A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells.
Journal: Journal of food and drug analysis
Published: June 05, 2021
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Journal: Theranostics
Published: September 18, 2020
4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy.
Journal: Bioorganic chemistry
Published: November 30, 2017
Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells.
Journal: Free radical biology & medicine
Published: February 27, 2017
LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
Journal: Oncotarget
Published: January 22, 2015
IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer.
Journal: Journal of cellular physiology
Published: February 17, 2014
Endothelin-1 stimulates suppressor of cytokine signaling-3 gene expression in adipocytes.
Journal: General and comparative endocrinology
Published: January 19, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026